This pdf contain notes on STERILE DOSAGE FORM (PARENTRA), This notes is specilly used for D. pharm, B. Pharm & M. Pharm Students and respected faculties
This pdf contain notes on STERILE DOSAGE FORM (PARENTRA), This notes is specilly used for D. pharm, B. Pharm & M. Pharm Students and respected faculties
Manufacture of parenteral products and troubleshootingMostafaQalavand1
Parenteral administration of drugs by intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes is now an established and essential part of medical practice.
Many important drugs are available only as parenteral dosage forms. Notable among these are numerous biotechnology drugs, insulin, several cephalosporin antibiotic products, and drugs such as heparin, protamine, and glucagon. In addition, other drugs such as lidocaine hydrochloride and many anticancer products are used principally as parenterals.
Introduction
Routes of administration of parenteral dosage form
Types of parenteral preparation
General requirements for parenteral dosage form
Formulation of parenteral preparations
Containers and closures used
Processing of parenteral preparations
Evaluation of parenteral preparations
Labeling and packaging
Production facilities
Preparation of iv fluids and admixtures
Sterlity testing
Particulate matter monitoring
Faculty seal packaging
PARENTERAL ROUTES OF DRUG ADMINISTRATIONZainab Riaz
PARENTERAL ROUTE OF DRUG ADMINISTRATION
The term parenteral refers to injectable routes of administration of drug.
So as a hole it means outside of intestine.
PARENTRAL MEDICATIONS AND STERILE FLUIDS:
The parenteral route of drug administration are:
1. Intravenous IV
2. Intramuscular IM
3. Intradermal
4. Subcutaneous
PYROGENS: The water used in parenteral should be free of pyrogens.
METHODS OF REMOVING PYROGENS:
1. Distillation
2. Reverse osmosis
3. Heating at 180 degree celcius for 3 to 4 hours
4. Adsorption method
OFFICIAL TYPES OF INJECTIONS:
SOLVENTS AND VEHICLES USED FOR INJECTIONS:
STERILE WATER FOR INJECTION USP
BACTERIOSTATIC WATER FOR INJECTION
NaCl injection USP
BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP
RINGER INJECTION USP
LACTATED RINGER INJECTION USP
NON AQUEOUS VEHICLES
ADDED SUBSTANCES USED IN PARENTERALS
SOLUBILIZING AGENTS
STABILIZERS
ANTIMICROBIAL AGENTS
ANTI OXIDANTS USED IN PARENTERALS.
Manufacture of parenteral products and troubleshootingMostafaQalavand1
Parenteral administration of drugs by intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes is now an established and essential part of medical practice.
Many important drugs are available only as parenteral dosage forms. Notable among these are numerous biotechnology drugs, insulin, several cephalosporin antibiotic products, and drugs such as heparin, protamine, and glucagon. In addition, other drugs such as lidocaine hydrochloride and many anticancer products are used principally as parenterals.
Introduction
Routes of administration of parenteral dosage form
Types of parenteral preparation
General requirements for parenteral dosage form
Formulation of parenteral preparations
Containers and closures used
Processing of parenteral preparations
Evaluation of parenteral preparations
Labeling and packaging
Production facilities
Preparation of iv fluids and admixtures
Sterlity testing
Particulate matter monitoring
Faculty seal packaging
PARENTERAL ROUTES OF DRUG ADMINISTRATIONZainab Riaz
PARENTERAL ROUTE OF DRUG ADMINISTRATION
The term parenteral refers to injectable routes of administration of drug.
So as a hole it means outside of intestine.
PARENTRAL MEDICATIONS AND STERILE FLUIDS:
The parenteral route of drug administration are:
1. Intravenous IV
2. Intramuscular IM
3. Intradermal
4. Subcutaneous
PYROGENS: The water used in parenteral should be free of pyrogens.
METHODS OF REMOVING PYROGENS:
1. Distillation
2. Reverse osmosis
3. Heating at 180 degree celcius for 3 to 4 hours
4. Adsorption method
OFFICIAL TYPES OF INJECTIONS:
SOLVENTS AND VEHICLES USED FOR INJECTIONS:
STERILE WATER FOR INJECTION USP
BACTERIOSTATIC WATER FOR INJECTION
NaCl injection USP
BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP
RINGER INJECTION USP
LACTATED RINGER INJECTION USP
NON AQUEOUS VEHICLES
ADDED SUBSTANCES USED IN PARENTERALS
SOLUBILIZING AGENTS
STABILIZERS
ANTIMICROBIAL AGENTS
ANTI OXIDANTS USED IN PARENTERALS.
Ocular drug delivery system is a method to deliver drugs to the eye to treat various eye conditions. This includes eye drops, ointments, and implants, which are designed to improve drug efficacy, minimize side effects, and provide sustained drug release. It is an important area of research and development in the field of ophthalmology, as it enables targeted and effective treatment of eye diseases. Here we have discussed about various preparations along with their evaluation parameters.
Pharmacovigilance Risk Management for BiosimilarsCovance
This paper focuses on pharmacovigilance (PV) and risk management for biosimilars, the issues and challenges faced in monitoring their safety and possible solutions.
Similar to Biosimilars :A New Horizon in Ocular Therapeutics. (20)
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
2. OCULAR THERAPEUTICS
Eye is a complex system in itself
Challenging for the Pharmacologist and Ophtholmologists
Aims at maximum bioavailability of drug with minimum
toxicity to other tissues
6. BIOLOGICS……???
Journey of ocular therapeutics started from eye drop to
NODDS now included Biologics
Complex Macromolecules made of Sugars, aminoacids
Vaccines, blood components or may be living entitities
cells tissues all are biologics
7. CONS OF BIOLOGICS
High Cost Involved
Long Time in development
Longer Clinical Trials
8. What
Next:BIOSIMILAR…….??
A biosimilar is a biological product that is highly similar to
and has no clinically meaningful differences from an
existing FDA-approved reference product..
9. REFERENCE PRODUCT
A reference product is the single biological product, already
approved by FDA, against which a proposed biosimilar
product is compared. A reference product is approved
based on, among other things, a full complement of safety
and effectiveness data.
10. PROS
Prove similarity in pharmacokinetics
pharmacodynamics,immunogenecity safety & efficacy
Cost involved vs profit
Cost & time involved is less
11. CONS
Living cells :No Fixed chemical formula
No complete information in terms of manufacturing.
It makes the development of biosimilars difficult
12. POTENTIAL BIOSIMILARS
Razumab Biosimilar of Ranizumab (Intas
Pharm)
Approved for use in Wet AMD ,RVO,DME etc
& CNV
Adalimumab (Humira) (Abott) Non infectious
uveitis.
13. FUTURE PROSPECTIVES
Discounts of 15%-30% compared to the reference product
in U.S while in Europe there have been examples of 30%-
40% cuts.
India being a developing country is being a great hub for
biosimilars because of its affordability.
Biosimilars have bright future expectations globally.